IR@PKUHSC  > 北京大学第二临床医学院  > 病理科
学科主题临床医学
New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma
Liu, Fangfang1; Shen, Danhua1; Kang, Xiaoping2; Zhang, Chunfang3; Song, Qiujing1
刊名JOURNAL OF CLINICAL PATHOLOGY
2015-11-01
DOI10.1136/jclinpath-2015-202978
68期:11页:913-916
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pathology
资助者National Science Foundation of China ; Beijing National Science Foundation ; National Science Foundation of China ; Beijing National Science Foundation
研究领域[WOS]Pathology
关键词[WOS]COLORECTAL-CARCINOMA ; EXPRESSION ; PLACENTA ; GENE
英文摘要

Aim To evaluate protein expression and clinical significance of PLAC1/CP1 antigen in primary gastric adenocarcinoma.

Methods Protein expression of PLAC1/CP1 was analysed by tissue chip and immunohistochemistry in surgical specimens obtained from 119 patients with gastric cancer. The data were analysed using SPSS V. 16.0 software applying the chi(2) test and Kaplan-Meier method.

Results The positive expression frequency of PLAC1/CP1 protein was 61.3% (73/119 patients). The overall survival of patients with PLAC1/CP1 protein-positive expression was significantly lower than that of patients with PLAC1/CP1 protein-negative expression (p<0.05). There was no significant relationship between PLAC1/CP1 expression and patient gender, age, tumour position, tumour size, differentiation, gross type, lymph node or TNM stage.

Conclusions PLAC1/CP1 protein is expressed in over half of cases of primary gastric cancer, and PLAC1/CP1 protein expression is inversely correlated with patient survival. The data indicate that PLAC1/CP1 provides a marker for identifying gastric cancers with poor prognosis, and suggest that PLAC1/CP1 may provide a useful target for immunotherapy.

语种英语
所属项目编号30801093 ; 2101000262 ; 7122195
资助者National Science Foundation of China ; Beijing National Science Foundation ; National Science Foundation of China ; Beijing National Science Foundation
WOS记录号WOS:000364997000009
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59257
专题北京大学第二临床医学院_病理科
作者单位1.Peking Univ, Peoples Hosp, Dept Pathol, Beijing 100044, Peoples R China
2.Peking Univ, Dept Stat Off, Hlth Sci Ctr, Beijing 100044, Peoples R China
3.Peking Univ, Peoples Hosp, Dept Clin Epidemiol, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Liu, Fangfang,Shen, Danhua,Kang, Xiaoping,et al. New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma[J]. JOURNAL OF CLINICAL PATHOLOGY,2015,68(11):913-916.
APA Liu, Fangfang,Shen, Danhua,Kang, Xiaoping,Zhang, Chunfang,&Song, Qiujing.(2015).New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma.JOURNAL OF CLINICAL PATHOLOGY,68(11),913-916.
MLA Liu, Fangfang,et al."New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma".JOURNAL OF CLINICAL PATHOLOGY 68.11(2015):913-916.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Fangfang]的文章
[Shen, Danhua]的文章
[Kang, Xiaoping]的文章
百度学术
百度学术中相似的文章
[Liu, Fangfang]的文章
[Shen, Danhua]的文章
[Kang, Xiaoping]的文章
必应学术
必应学术中相似的文章
[Liu, Fangfang]的文章
[Shen, Danhua]的文章
[Kang, Xiaoping]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。